NDC80 (NDC80, kinetochore complex component)

2017-10-01   Manuela Ferrara , Francesca Degrassi 

Institute of Molecular Biology and Pathology, Italian National Research Council, c\\\/o Sapienza University, via degli Apuli 4, 00185 Rome, Italy francesca.degrassi@uniroma1.it

Identity

HGNC
LOCATION
18p11.32
LOCUSID
ALIAS
HEC,HEC1,HsHec1,KNTC2,TID3,hsNDC80

DNA/RNA

Description

The human NDC80 gene lies on the p arm of chromosome 18, close to the telomeric region; Position 2,571,511 to 2,616,635, forward strand (Ensembl ID: ENSG00000080986).

Transcription

The full mRNA comprises 2172 bp (Ensembl ID: ENST00000261597.8). The transcript contains 17 exons. Ensembl reports the existence of 5 splice variants. Analysis of the 5-flanking region showed that it contains binding sites for cAMP responsive element binding (CREB) and activating transcription factor 4 (ATFA or CREB 2) proteins that positively regulate transcription (Cheng et al, 2007).

Pseudogene

No pseudogenes are described in humans.

Proteins

Description

642 aa; 73.9 kDa.
"Highly Expressed in Cancer protein 1" (Hec1) is the name of the human homologue of the Ndc80 protein. It was originally identified as an interactor of the retinoblastoma (pRb) protein in the yeast two-hybrid system (Chen et al, 1997). It was subsequently re-isolated as an interactor of the mitotic checkpoint protein MAD1L1 (Martin-Lluesma et al, 2002).
Hec1 interacts with three other kinetochore proteins ( NUF2, SPC25 and SPC24 ) to form the Ndc80 kinetochore complex that is required for establishing stable interactions between the kinetochore and microtubules (Ciferri et al, 2005; DeLuca et al, 2006; DeLuca & Musacchio, 2012). The complex has an elongated rod-like structure that spans ~60 nm, with globular domains at both ends. The globular domains of Nuf2 and Hec1 interact with the microtubules at one end whereas the Spc24-Spc25 globular heads constitute the centromere binding domain of the complex
The crystal structure of a truncated version of the Ndc80 complex has been resolved and different Hec1 structural domains have been identified (Ciferri et al, 2008). The N-terminus comprises an unstructured tail domain (aa 1-80) which is highly basic and positively charged. The Hec1 tail is required for the efficient formation of stable kinetochore-microtubule attachments in mammalian cultured cells (Guimaraes et al, 2008; Miller et al, 2008) and the affinity for microtubules of the entire complex is modulated by AURKB (Aurora B)-mediated phosphorylation on Ser8, Ser44, Ser15, Ser55 residues within the tail domain
A second portion of the N terminus folds into a Calponin Homology (CH) domain (aa 81-196), a motif found in actin- and microtubule-binding proteins. The CH domain contributes to microtubule binding and attachment stability through a direct interaction between a positively charged regionin the CH domain and a negative region at the alpha and beta tubulin interface on microtubules (Alushin et al, 2010). Within the CH domain, Ser165 is phosphorylated by the mitotic NEK2 (NEK2A) kinase and expression of a non -phosphorylatable Hec1 has been shown to perturb chromosome congression and increase the number of erroneous kinetochore-microtubule interactions (Du et al, 2008).
The long coiled-coil region (aa 261-445) interacts with a similar region of Nuf2 producing the elongated rod-like structure. This domain is interrupted by a loop region in Ndc80 (aa 426-459), forming a kink in the Ndc80 complex structure. This region is required to establish end-on microtubule attachments to kinetochores through the binding of the spindle and kinetochore associated (Ska) complex and the Ctd1 replication licensing factor (Wan et al, 2009; Zhang et al, 2012; Varma et al, 2012). Finally, the C terminus (446-642) takes part in a tetramerization domain where the Ndc80/Nuf2and Spc24/Spc25 dimers interact (Ciferri et al, 2005).

Expression

The protein is present in actively proliferating tissues such as testis, spleen and thymus in mice (Chen et al, 1997). Hec1 expression is cell cycle regulated. In both untransformed and cultured cancer cells, the protein appears in late S and remains at high levels until mitosis, when it is down-regulated through anaphase promoting complex/cyclosome-Cdh1 (APC/C-Cdh1) and proteasome-mediated degradation  (Li et al, 2011; Ferretti et al, 2010).

Localisation

Hec1 is a mitotic kinetochore protein. It localizes to nuclei in S phase and G2 cells. At the beginning of mitosis the protein localizes to the outer layer of the kinetochore (Wan et al, 2009), where it persists until it is degraded at the end of mitosis (Figure 1).
Atlas Image
Fig 1. Hec1 localization in human cells. Immunofluorescence images of HeLa cells stained with DAPI (blue) and anti-Hec1 antibody (red). Hec1 is nuclear in interphase G2 cells, localizes to kinetochores at all mitotic stages and is degraded from kinetochores at telophase.

Function

Kinetochore-microtubule interactions:
Faithful chromosome segregation occurs when the two sister kinetochores are connected to microtubules emanating from different spindle poles (amphitelic attachment). However, in the early stages of mitosis non functional kinetochore-microtubule interactions (syntelic and merotelic attachments) intervene and must be corrected before anaphase to impede chromosome mis-segregation and aneuploidy (Cimini & Degrassi, 2005). Hec1 is a constituent of the evolutionary conserved Ndc80/Hec1 complex that mediates the attachment of sister chromatids to the mitotic spindle and is therefore implicated in producing amphitelic end-on attachments and directing chromosome movements during mitosis (Tooley & Stukenberg, 2011). Molecular affinity beetween Hec1 and microtubules is mediated by electrostatic interactions involving positively charged amino acid residues on the Hec1 tail and CH domain that interact with negatively charged residues on microtubules (Ciferri et al, 2008; Sundin et al, 2011; Tooley et al, 2011). Consequently, the temporally regulated phosphorylation of Hec1 N terminal tail by Aurora B kinase during prometaphase decrease the affinity of the Ndc80 complex to microtubules, allowing the detachment of erroneous kinetochore-microtubule interactions and enabling the formation of new correct attachments (Zaytsev et al, 2014; DeLuca et al, 2011). Phosphorylation by NEK2A kinase of the CH domain also contributes to this process . Finally, kinetochore-microtubule attachments are stabilized by the recruitment of the Ska complex and Cdt1 at the Ndc80 internal loop to form functional end-on attachments (Zhang et al, 2012; Varma et al, 2012).
Mitotic checkpoint signaling :
Several pieces of evidence indicate that Hec1 plays a positive role in the spindle assembly checkpoint (SAC). This conserved cellular mechanism inhibits anaphase onset until all kinetochores are amphitelically attached to the microtubules and inter-kinetochore tension is present . Unattached kinetochores recruit SAC components that are then released from kinetochores to inhibit the anaphase promoting complex/cyclosome necessary for sister chromatid separation and mitotic exit (Musacchio, 2015). The Ndc80 complex is a structural component of the kinetochore and is required for proper SAC control as it recruits the ZW10 complex (Lin et al, 2006; Kops et al, 2005) that is essential for the binding of the master checkpoint proteins MAD1L1 and MAD2L1 to kinetochore (Martin-Lluesma et al, 2002; DeLuca et al, 2003). Furthermore, Hec1 has been shown to specify the kinetochore localization of the checkpoint kinase TTK (Mps1) via its microtubule binding domain (Stucke et al, 2004; Zhu et al, 2013). Hec1 phosphorylation by Aurora B kinase weakens the kinetochore-microtubule interaction but promotes Hec1 binding to Mps1, suggesting a concerted regulation between kinetochore attachment and checkpoint signaling (Zhu et al, 2013; Hiruma et al, 2015). Significantly, recent work has shown that formation of stable kinetochore- microtubule attachments, irrespective of inter-kinetochore tension, is sufficient to satisfy the SAC in human cells (Tauchman et al, 2015)

Implicated in

Entity name
Various Cancer
Oncogenesis
Ndc80/Hec1 is a constituent of the NDC80 complex. The complex is required for accurate chromosome segregation in mitosis, as it is essential for generating bipolar end-on kinetochore-microtubule attachments, which are responsible for the faithful anaphase segregation of sister chromatids (DeLuca & Musacchio, 2012). Chromosome mis-segregation results in genome instability, which is a hallmark of cancer. The crucial role of the NDC80 complex in chromosome segregation during mitosis, the recurrent HEC1 upregulation in different human cancers (as described in sections below) and its dependence on pRb deficiency (Ferretti et al, 2010) suggest that Hec1 deregulation may be an important step in the multistage process of tumorigenesis. Concordantly, Hec1 depletion by RNa interference (RNAi) leads to defective mitotic checkpoint signaling, defective chromosome alignment to the metaphase plate and massive chromosome mis-segregation and apoptosis (Martin-Lluesma et al, 2002; Kaneko et al, 2009; Mattiuzzo et al, 2011; Linton et al, 2014; Ju et al, 2017). Interestingly, Hec1 overexpression in an inducible mouse model has been shown to promote chromosome instability in embryonic fibroblasts and tumor formation in different mouse tissues (Diaz-Rodriguez et al, 2008). Moreover, NDC80 is one of the genes defining a 11 gene signature associated with poor prognosis in multiple cancer types (Glinsky et al, 2005). This signature identifies a metastasis-enabling, anoikis-resistant, aneuploid-prone phenotype (Glinsky, 2006).
Entity name
Breast Cancer
Oncogenesis
A real-time reverse transcription polymerase chain reaction (RT-PCR) study investigated expression of 76 mitotic spindle checkpoint genes in a large panel of breast tumor samples (including normal breast tissues, benign breast tumors, ductal carcinoma in situ, and grade I and III invasive ductal breast tumors). The study identified NDC80/Hec1 as one of the genes markedly upregulated in ductal grade III breast tumors. More interestingly, Ndc80 was specifically involved in the transition from normal breast tissues to benign breast tumors. Indeed, it was found as the most strongly upregulated gene in benign breast tumors, being its levels > 3-fold higher in begnin tumors than in normal breast tissues (Bièche et al, 2011). Moreover, NDC80 is part of several multigene expression profiles, which are commonly used in clinical settings to characterize breast cancer tissues for individualization of therapy (Koleck & Conley, 2016).
A study on the relationships between host single-nucleotide polymorphisms (SNPs) and pretreatment cognitive performance in post-menopausal women diagnosed with early stage breast cancer has identified Ndc80 as one of 22 genes with a positive association between host polymorphisms and improvement in cognitive function performance (Koleck et al, 2017).
Entity name
Pancreatic Cancer
Oncogenesis
NDC80 mRNA and protein have been found overexpressed in pancreatic cancer tissues and in pancreatic cancer cell lines (Meng et al, 2015). Immunohistochemical evaluation of human pancreatic cancer tissues suggested that Ndc80 overexpression is significantly associated with clinicopathological parameters, including pathological T staging and N staging, which are predictors of poor prognosis (Meng et al, 2015).
Entity name
Liver Cancer
Oncogenesis
NDC80 expression has been analyzed by RT-PCR in 42 paired hepatocellular carcinoma (HCC) and adjacent tissues. The study has revealed that NDC80 levels are significantly higher in HCC cells as compared with adjacent tissues (Ju et al, 2017). A gene expression profile dataset of 10 HCC and 10 control samples analysed for gene ontology has identified NDC80 as member of a group of cell division-related genes that are up-regulated in HCC. Moreover, Ndc80 has been identified as an "hub" protein in HCC cancer, as revealed by protein-protein interaction network construction and module detection using the STRING online tool (Yan et al, 2017).
Entity name
Gastric Cancer
Oncogenesis
mRNA overexpression of the four genes comprising the Ndc80 complex has been observed in primary resected gastric cancers when compared with the corresponding normal mucosae (Kaneko et al, 2009). More recently, RT-PCR and immunohistochemical staining of 42 gastric cancer and paired non-cancer tissues showed higher expression of both Hec1 mRNA and protein in gastric cancers as compared with non-tumor tissues. Hec1 staining was observed in 90% of cancer samples whereas positive staining was rarely observed in non cancer tissues. Positive staining of Hec1 was also observed in dysplasia glands, a precancerous lesion, suggesting an important role of Hec1 in the early stage of gastric tumorigenesis (Qu et al, 2014).
Entity name
Prostate Cancer
Oncogenesis
Hec1 mRNA overexpression has been detected in human Prostate Cancer (PCa) tissues and higher mRNA and protein levels have been found in several PCa cell lines (Wang et al, 2015). The same study has also identified a long-non-coding RNA (LncRNA BX647187) as up-regulated in human PCa tissues and cell lines. The study also showed that LncRNA levels are positively regulated by Hec1, as they were strongly reduced upon Hec1 depletion. Interestingly, suppression of BX647187 significantly reduced cell proliferation and promoted apoptosis of PCa cells (Wang et al, 2015).
Entity name
Colon cancer
Oncogenesis
Overexpression of Ndc80 mRNA has been reported in colorectal cancer tissues (Kaneko et al, 2009; Miyata et al, 2015). High levels of Ndc80 protein have been also observed in several colon cancer cell lines (Xing et al, 2016). Immunohistochemical analysis on tissue samples demonstrated that the rate of Ndc80-positive cells was significantly higher in colon cancer specimens than in normal colon tissues. Faster cell proliferation and greater migration ability was observed in colorectal SW480 cells transfected with an Ndc80-expressing vector as compared to controls (Xing et al, 2016).
Entity name
Oligodendrogliomas
Oncogenesis
A study of microarray and RNA sequencing on normal brain tissue as compared to grade II and III oligodendrogliomas (ODs) has identified a co-expression network of six mitosis-regulating genes (NDC80 is among these) associated with malignant progression and prognosis in ODs. Validation by quantitative PCR of the six gene network has been obtained in a second group of ODs patients. (Liu et al, 2015).
Entity name
Lung Cancer
Oncogenesis
Co-overexpression of Nuf2 and Ncd80, members of the evolutionarily conserved centromere protein complex (Ndc80), has been found in non-small cell lung carcinomas (NSCLC) and NSCLC cell lines (Hayama et al, 2006). Immunohistochemical analysis using lung cancer tissue microarray confirmed high levels of the two proteins in the great majority of lung cancers of various histological types (Hayama et al, 2006). The same study demonstrated that NSCLC patients with abundant expression of Nuf2/Ndc80 experience a shorter tumor-specific survival period (Hayama et al, 2006).
Entity name
Ovarian Cancer
Oncogenesis
A RNA interference lethality screen of the human druggable genome has identified NDC80 among the four genes with a role in growth or survival of ovarian cancer cell lines. The study demonstrated that ovarian tumorigenic cells are comparatively more vulnerable to Ndc80 down-regulation compared with non-tumorigenic cells. Finally, Ndc80 was found overexpressed in nearly 100% of the samples in two independent cohorts of patient samples (Sethi et al, 2012).
Entity name
Endometrial Cancer
Oncogenesis
A study of cDNA microarray has identified NDC80 as an up-regulated gene in serous endometrial adenocarcinomas. NDC80 was found to be member of a cluster of 46 genes exhibiting >2-fold differences in expression between serous endometrial adenocarcinomas and endometrioidones. Quantitative PCR and immunohistochemistry for Ndc80 confirmed the array results. Using unsupervised and supervised statistical analyses, this gene cluster has been demonstrated to statistically differentiate the two types of adenocarcinomas (Chen et al, 2011).

Bibliography

Pubmed IDLast YearTitleAuthors
209447402010The Ndc80 kinetochore complex forms oligomeric arrays along microtubules.Alushin GM et al
213525792011Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy.Bièche I et al
93156641997HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis.Chen Y et al
215400262011cDNA microarray analysis and immunohistochemistry reveal a distinct molecular phenotype in serous endometrial cancer compared to endometrioid endometrial cancer.Chen Y et al
178227872007Functional characterization of the promoter of human kinetochore protein HEC1: novel link between regulation of the cell cycle protein and CREB family transcription factors.Cheng L et al
159614012005Architecture of the human ndc80-hec1 complex, a critical constituent of the outer kinetochore.Ciferri C et al
184559842008Implications for kinetochore-microtubule attachment from the structure of an engineered Ndc80 complex.Ciferri C et al
160238552005Aneuploidy: a matter of bad connections.Cimini D et al
171297822006Kinetochore microtubule dynamics and attachment stability are regulated by Hec1.DeLuca JG et al
146540012003Nuf2 and Hec1 are required for retention of the checkpoint proteins Mad1 and Mad2 to kinetochores.DeLuca JG et al
221549442012Structural organization of the kinetochore-microtubule interface.DeLuca JG et al
212664672011Temporal changes in Hec1 phosphorylation control kinetochore-microtubule attachment stability during mitosis.DeLuca KF et al
189409252008Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo.Diaz-Rodríguez E et al
182971132008The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability.Du J et al
266217792015Kinetochore-microtubule attachment is sufficient to satisfy the human spindle assembly checkpoint.Etemad B et al
289253952018Small molecules targeted to the microtubule-Hec1 interaction inhibit cancer cell growth through microtubule stabilization.Ferrara M et al
209483162010Expression of the kinetochore protein Hec1 during the cell cycle in normal and cancer cells and its regulation by the pRb pathway.Ferretti C et al
167606512006Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneuploid, anoikis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway.Glinsky GV et al
159313892005Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.Glinsky GV et al
161212062006RNA interference against Hec1 inhibits tumor growth in vivo.Gurzov EN et al
170794542006Activation of CDCA1-KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis.Hayama S et al
260688552015CELL DIVISION CYCLE. Competition between MPS1 and microtubules at kinetochores regulates spindle checkpoint signaling.Hiruma Y et al
286115202017Effect of NDC80 in human hepatocellular carcinoma.Ju LL et al
198786542009siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis.Kaneko N et al
284245602017An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.Koleck TA et al
270223012016Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.Koleck TA et al
158241312005ZW10 links mitotic checkpoint signaling to the structural kinetochore.Kops GJ et al
247735492014Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.Lee YS et al
173300852007Development of recombinant adeno-associated virus vectors carrying small interfering RNA (shHec1)-mediated depletion of kinetochore Hec1 protein in tumor cells.Li L et al
211990052011Anaphase-promoting complex/cyclosome controls HEC1 stability.Li L et al
167323272006Hec1 sequentially recruits Zwint-1 and ZW10 to kinetochores for faithful chromosome segregation and spindle checkpoint control.Lin YT et al
243270152014An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.Linton A et al
264689832015Co-expression of mitosis-regulating genes contributes to malignant progression and prognosis in oligodendrogliomas.Liu Y et al
123517902002Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2.Martin-Lluesma S et al
212979792011Abnormal kinetochore-generated pulling forces from expressing a N-terminally modified Hec1.Mattiuzzo M et al
261759412015Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.Meng QC et al
190265422008Kinetochore attachments require an interaction between unstructured tails on microtubules and Ndc80(Hec1).Miller SA et al
264064032015Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.Miyata Y et al
264853652015The Molecular Biology of Spindle Assembly Checkpoint Signaling Dynamics.Musacchio A et al
251322622015N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics.Orticello M et al
235917672014Hec1/Ndc80 is overexpressed in human gastric cancer and regulates cell growth.Qu Y et al
230565892012An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.Sethi G et al
152357932004Kinetochore localization and microtubule interaction of the human spindle checkpoint kinase Mps1.Stucke VM et al
212704392011The NDC80 complex proteins Nuf2 and Hec1 make distinct contributions to kinetochore-microtubule attachment in mitosis.Sundin LJ et al
266204702015Stable kinetochore-microtubule attachment is sufficient to silence the spindle assembly checkpoint in human cells.Tauchman EC et al
213119652011The Ndc80 complex: integrating the kinetochore's many movements.Tooley J et al
213256302011The Ndc80 complex uses a tripartite attachment point to couple microtubule depolymerization to chromosome movement.Tooley JG et al
225810552012Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required for stable kinetochore-microtubule attachment.Varma D et al
194505152009Protein architecture of the human kinetochore microtubule attachment site.Wan X et al
266120022015The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 in vitro.Wang H et al
171897162007Aneuploidy acts both oncogenically and as a tumor suppressor.Weaver BA et al
189229122008Small molecule targeting the Hec1/Nek2 mitotic pathway suppresses tumor cell growth in culture and in animal.Wu G et al
271733282016NDC80 promotes proliferation and metastasis of colon cancer cells.Xing XK et al
282385422017Aberrant expression of cell cycle and material metabolism related genes contributes to hepatocellular carcinoma occurrence.Yan H et al
249824302014Accurate phosphoregulation of kinetochore-microtubule affinity requires unconstrained molecular interactions.Zaytsev AV et al
224545172012The Ndc80 internal loop is required for recruitment of the Ska complex to establish end-on microtubule attachment to kinetochores.Zhang G et al

Other Information

Locus ID:

NCBI: 10403
MIM: 607272
HGNC: 16909
Ensembl: ENSG00000080986

Variants:

dbSNP: 10403
ClinVar: 10403
TCGA: ENSG00000080986
COSMIC: NDC80

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000080986ENST00000261597O14777
ENSG00000080986ENST00000261597A8K031
ENSG00000080986ENST00000574096I3L0P0
ENSG00000080986ENST00000575515I3L4G3
ENSG00000080986ENST00000576274V9GYM9

Expression (GTEx)

0
5
10
15
20
25
30
35
40

Pathways

PathwaySourceExternal ID
Signal TransductionREACTOMER-HSA-162582
Signaling by Rho GTPasesREACTOMER-HSA-194315
RHO GTPase EffectorsREACTOMER-HSA-195258
RHO GTPases Activate ForminsREACTOMER-HSA-5663220
Cell CycleREACTOMER-HSA-1640170
Cell Cycle, MitoticREACTOMER-HSA-69278
M PhaseREACTOMER-HSA-68886
Mitotic PrometaphaseREACTOMER-HSA-68877
Resolution of Sister Chromatid CohesionREACTOMER-HSA-2500257
Mitotic Metaphase and AnaphaseREACTOMER-HSA-2555396
Mitotic AnaphaseREACTOMER-HSA-68882
Separation of Sister ChromatidsREACTOMER-HSA-2467813

References

Pubmed IDYearTitleCitations
171297822006Kinetochore microtubule dynamics and attachment stability are regulated by Hec1.318
159313892005Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.297
184559842008Implications for kinetochore-microtubule attachment from the structure of an engineered Ndc80 complex.246
123517902002Role of Hec1 in spindle checkpoint signaling and kinetochore recruitment of Mad1/Mad2.186
209447402010The Ndc80 kinetochore complex forms oligomeric arrays along microtubules.151
171958482007The Ndc80/HEC1 complex is a contact point for kinetochore-microtubule attachment.145
212664672011Temporal changes in Hec1 phosphorylation control kinetochore-microtubule attachment stability during mitosis.113
155485922005Hec1 and nuf2 are core components of the kinetochore outer plate essential for organizing microtubule attachment sites.105
159614012005Architecture of the human ndc80-hec1 complex, a critical constituent of the outer kinetochore.83
225613462012CENP-T proteins are conserved centromere receptors of the Ndc80 complex.80

Citation

Manuela Ferrara ; Francesca Degrassi

NDC80 (NDC80, kinetochore complex component)

Atlas Genet Cytogenet Oncol Haematol. 2017-10-01

Online version: http://atlasgeneticsoncology.org/gene/41095/ndc80-(ndc80-kinetochore-complex-component)